Industry Leaders Gather at Medidata NEXT Global 2017 to Discuss How Technology is Transforming Clinical Research
October 02 2017 - 8:30AM
Business Wire
Medidata Hosts Forum on Latest in Clinical
Trial Innovation to Accelerate the Delivery of Life Changing
Patient Treatments
Medidata (NASDAQ:MDSO), the leading global provider of
cloud-based technology and data analytics for clinical research,
announced that Medidata NEXT Global will take place in New York, at
Spring Studios from November 8-10. The event will host 89 sessions
and eight keynotes, with over half led by Medidata customers and
CRO partners; including senior executives and experts from
Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Memorial Sloan
Kettering, Worldwide Clinical Trials, Accenture and more. Medidata
NEXT Global is the centerpiece of the largest annual event series
of its kind, attracting over 3,000 attendees across events in
Basel, Berlin, London, New York, Seoul, Shanghai and Tokyo.
Medidata NEXT is where science meets technology meets the
future, with interactive, hands-on learning opportunities to
design, execute, manage and monitor the next generation of clinical
research. The event will attract industry leaders in drug and
device development, clinical operations, data management,
biostatistics and digital medicine innovation for networking and
collaboration.
Medidata NEXT Global’s keynotes and presentations will feature
visionaries who are propelling the industry forward, such as Emory
University’s Frances Winship Walters Professor of Pediatrics &
Biochemical Pharmacology Director, Raymond Schinazi, PhD, whose
pioneering work on antiviral treatments has transformed HIV and
hepatitis C into manageable or curative conditions. The gathering
will also spotlight community leaders facilitating new techniques
for disease awareness, including T.J. Sharpe, patient advocate and
stage IV melanoma fighter, as well as Nancy Frates, mother of ALS
patient, Pete Frates, whose family championed the historic 2014 ALS
Ice Bucket Challenge.
During the event, thought-provoking breakout sessions will also
highlight cutting-edge innovation within each phase of the clinical
development lifecycle, covering areas like study planning, site
support, study conduct, patient engagement, and risk-based
monitoring. Experience firsthand how technology such as Medidata
Strategic Monitoring is enabling compliance with the implementation
of ICH E6 guidelines during an expert customer panel featuring
Celgene, Bristol-Myers Squibb and Karyopharm. Sessions include:
How Big Data and Analytics are Changing Clinical
TrialsSpeaker: David Lee, Medidata, Chief Data OfficerLearn how
to improve operational and scientific decision making for clinical
trials by harnessing Medidata's unique data sources and analytics.
This presentation will highlight how new data science solutions
including predictive models, machine learning and genomic analysis
can improve your clinical trials.
PARADE: Pharma's First Apple ResearchKit StudySpeaker:
Bill Lander, GSK, Director of Innovation and Clinical PlatformsGSK
Launched PARADE, the industry’s first implementation of Apple’s
ResearchKit™ in 2016. In this presentation, Bill Lander will walk
through the details of the set-up and implementation of this
project and key findings.
“Medidata NEXT Global is the ideal environment to see how our
integrated platform pushes scientific innovation, advances research
programs, and ultimately drives better clinical outcomes that
change lives,” said Glen de Vries, Medidata president and
co-founder. “At our NEXT Global event, we'll take a deep-dive into
how our intelligent, unified platform is the key to simplifying
complex processes that touch sponsors, CROs, sites and patients —
bringing together technology, data, processes and people.”
The NEXT Innovation Lounge will also feature a digital showcase
presented by healthcare tech innovator, HITLAB.
Register today to network with industry peers and engage in
discussions on how technology is redefining clinical research, thus
accelerating hope for patients worldwide.
About Medidata
Medidata is reinventing global drug and medical device
development by creating the industry's leading cloud-based
solutions for clinical research. Through our advanced applications
and intelligent data analytics, Medidata helps advance the
scientific goals of life sciences customers worldwide, including
over 850 global pharmaceutical companies, biotech, diagnostic and
device firms, leading academic medical centers, and contract
research organizations.
The Medidata Clinical Cloud® brings a new level of quality and
efficiency to clinical trials that empower our customers to make
more informed decisions earlier and faster. Our unparalleled
clinical trial data assets provide deep insights that pave the way
for future growth. The Medidata Clinical Cloud is the primary
technology solution powering clinical trials for 18 of the world's
top 25 global pharmaceutical companies and is used by 18 of the top
25 medical device developers—from study design and planning through
execution, management and reporting.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171002005527/en/
MedidataInvestors:Anthony D’Amico,
732-767-4331adamico@mdsol.comorMedia:Erik Snider,
646-362-2997esnider@mdsol.com
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Apr 2023 to Apr 2024